Brief Summary: This protocol will serve as a platform for assessing treatments for adult patients hospitalized…
Category: Studies
An International Observational Study to Characterize Adults Who Are Hospitalized With Influenza or Other Targeted Respiratory Viruses
Following the sudden and unexpected emergence of influenza A(H1N1)pdm09 (2009 H1N1) virus, this observational study was…
HBV and HCV in prison
This study is part of the LTBI in prison study. This study is the secondary objective.…
Multicenter clinical performance evaluation of the Molbio Diagnostics Truenat™ HCV RNA assay
This is a new diagnostic test to detect HCV with shorter turnaround time. This study will…
Test and Treat HIV and Viral Hepatitis for People Who Use Drugs and Their Partners in Thailand: The C-Free Study
This is a multi-center cohort study with a nested, open-label clinical trial. This study will: Assess…
Program to help develop and propel HCV treatment
This study offers HCV treatment for all HCV infected population.
B-enchancement of HBV vaccination in persons living with HIV (Bee-HIVe): Evaluation of HEPLISAV-B
The purpose of this study is to evaluate response to and safety of the HBV vaccine…
A Prospective, Multi-Centre Study (B-Sure) to Evaluate Long-Term Durability of Sustained Virologic Response in Chronic Hepatitis B Participants With and Without Nucleos(t)ide Therapy Who Have Received and Responded to GSK3228836 in a Previous Treatment Study
This is a long-term follow-up study to assess durability of efficacy, as measured by SVR, in…
A phase 2b multi-center, randomized, partial-blind parallel cohort study to assess the efficacy and safety of treatment with GSK3228836 in participants with chronic HBV
Chronic hepatitis B virus (HBV) infection is a significant worldwide medical problem. GSK3228836 demonstrated target engagement…
Safety, efficacy, immunogenicity study of GSK Biologicals’ HBV viral vector and adjuvanted proteins vaccine (GSK3528869A) in adult patients with chronic Hepatitis B infection
A First-Time-In-Human study on GSK’s therapeutic vaccines to evaluate the reactogenicity, safety, immunogenicity and efficacy on…
A phase 2, randomized, adaptive, open-label platform trial to evaluate efficacy and safety of multiple combination therapies in participants with chronic hepatitis B
This is a study designed to evaluate the safety, tolerability and efficacy of New Molecular Entity…
A Phase 3, Randomized, Double-Blind Study to Evaluate the Safety and Efficacy of Fixed Dose Combination of Bictegravir/Emtricitabine/Tenofovir Alafenamide versus Dolutegravir + Emtricitabine/Tenofovir Disoproxil Fumarate in Treatment Naïve, HIV-1 and Hepatitis B Co-Infected Adults
Bictegravir (GS-9883) is a potent inhibitor of HIV-1 integrase that is being evaluated for the treatment…
